Tuesday, September 15, 2026 · Mysuru
Subscribe
Star of Mysore - homeSTAR OF MYSORE
Mysuru's Evening Daily · Since 1978
Vol. XLVIII · No. 134 · Established 1978 · Founded by K.B. Ganapathy
Home/News/Jubilant launches ‘JUBI-R’ (remdesivir) …
News

Jubilant launches ‘JUBI-R’ (remdesivir) for COVID-19 treatment in India

Mysore/Mysuru: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its subsidiary, Jubilant Generics Limited (Jubilant), has launched remdesivir for injection under the brand name ‘JUBI-R’…

By Author
Published August 4, 2020 · 1 min read
jubilant launches ‘jubi-r’ (re

Mysore/Mysuru: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its subsidiary, Jubilant Generics Limited (Jubilant), has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of Rs. 4,700 per vial of 100 mg (lyophilized injection).

The Company will make the drug available to over 1,000 Hospitals providing COVID-19 treatment in India through its distribution network.

Continue reading

From the News desk
photo
News

Mysuru to get Township soon?

15 Jul 2026 · 4 min read
photo
News

MLC demands immediate appointment of MDA Commr.

15 Jul 2026 · 1 min read